Concentrations of Highly Sensitive Cardiac Troponin-I Predict Poor Cardiovascular Outcomes and Adverse Remodeling in Chronic Heart Failure

Journal of Cardiovascular Translational Research

Volumn 8, Issue 3, 2015, Pages 164-172

  Motiwala, Shweta R ^a   Gaggin, Hanna K ^b   Gandhi, Parul U ^b   Belcher, Arianna ^b   Weiner, Rory B ^b   Baggish, Aaron L ^b   Szymonifka, Jackie ^b   Januzzi, James L ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Biomarker; Heart failure; Prognosis; Remodeling; Troponin

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); TROPONIN I;

AGED; BLOOD; CARDIAC MUSCLE; CHI SQUARE DISTRIBUTION; CHRONIC DISEASE; DISEASE COURSE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; ODDS RATIO; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLE; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NECROSIS; ODDS RATIO; PEPTIDE FRAGMENTS; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SYSTOLE; TIME FACTORS; TROPONIN I; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84939964004     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-015-9618-4     Document Type: Article

References (14)

1. Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., Joint ESCAAHAWHFTFftUDoMI, Katus, H. A., Lindahl, B., Morrow, D. A., Clemmensen, P. M., Johanson, P., Hod, H., Underwood, R., Bax, J. J., Bonow, R. O., Pinto, F., Gibbons, R. J., Fox, K. A., Atar, D., Newby, L. K., Galvani, M., Hamm, C. W., Uretsky, B. F., Steg, P. G., Wijns, W., Bassand, J. P., Menasche, P., Ravkilde, J., Ohman, E. M., Antman, E. M., Wallentin, L. C., Armstrong, P. W., Simoons, M. L., Januzzi, J. L., Nieminen, M. S., Gheorghiade, M., Filippatos, G., Luepker, R. V., Fortmann, S. P., Rosamond, W. D., Levy, D., Wood, D., Smith, S. C., Hu, D., Lopez-Sendon, J. L., Robertson, R. M., Weaver, D., Tendera, M., Bove, A. A., Parkhomenko, A. N., Vasilieva, E. J., & Mendis, S. (2012). Third universal definition of myocardial infarction. Circulation, 126(16), 2020–2035. doi:10.1161/CIR.0b013e31826e1058.
2. Januzzi, J. L., Jr., Filippatos, G., Nieminen, M., & Gheorghiade, M. (2012). Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. European Heart Journal, 33(18), 2265–2271. doi:10.1093/eurheartj/ehs191.
3. Horwich, T. B., Patel, J., MacLellan, W. R., & Fonarow, G. C. (2003). Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation, 108(7), 833–838. doi:10.1161/01.CIR.0000084543.79097.34.
4. Wang, T. J., Wollert, K. C., Larson, M. G., Coglianese, E., McCabe, E. L., Cheng, S., Ho, J. E., Fradley, M. G., Ghorbani, A., Xanthakis, V., Kempf, T., Benjamin, E. J., Levy, D., Vasan, R. S., & Januzzi, J. L. (2012). Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation, 126(13), 1596–1604. doi:10.1161/CIRCULATIONAHA.112.129437.
5. de Lemos, J. A., Drazner, M. H., Omland, T., Ayers, C. R., Khera, A., Rohatgi, A., Hashim, I., Berry, J. D., Das, S. R., Morrow, D. A., & McGuire, D. K. (2010). Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA, 304(22), 2503–2512. doi:10.1001/jama.2010.1768.
6. Egstrup, M., Schou, M., Tuxen, C. D., Kistorp, C. N., Hildebrandt, P. R., Gustafsson, F., Faber, J., Goetze, J. P., & Gustafsson, I. (2012). Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure. The American Journal of Cardiology, 110(4), 552–557. doi:10.1016/j.amjcard.2012.04.033.
7. Masson, S., Anand, I., Favero, C., Barlera, S., Vago, T., Bertocchi, F., Maggioni, A. P., Tavazzi, L., Tognoni, G., Cohn, J. N., Latini, R., & Valsartan Heart Failure T, Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure I. (2012). Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Circulation, 125(2), 280–288. doi:10.1161/CIRCULATIONAHA.111.044149.
8. Gaggin, H. K., Szymonifka, J., Bhardwaj, A., Belcher, A., De Berardinis, B., Motiwala, S., Wang, T. J., & Januzzi, J. L., Jr. (2014). Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. JACC Heart Failure, 2(1), 65–72. doi:10.1016/j.jchf.2013.10.005.
9. Januzzi, J. L., Jr., Rehman, S., Mohammed, A. A., Bhardwaj, A., Barajas, L., Barajas, J., Kim, H.-N., Baggish, A. L., Weiner, R. B., Chen, A. A., Marshall, J. E., Moore, S. A., Carlson, W. D., Lewis, G. D., Shin, J., Sullivan, D., Parks, K., Wang, T. J., Gregory, S., Uthamalingam, S., & Semigran, M. J. (2011). Use of amino-terminal pro-B type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. Journal of the American College of Cardiology, 58, 1881–1889.
10. Bhardwaj, A., Rehman, S. U., Mohammed, A., Baggish, A. L., Moore, S. A., & Januzzi, J. L., Jr. (2010). Design and methods of the pro-B type natriuretic peptide outpatient tailored chronic heart failure therapy (PROTECT) Study. American Heart Journal, 159(4), 532–538. doi:10.1016/j.ahj.2010.01.005. e531.
11. Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., Solomon, S. D., Spencer, K. T., Sutton, M. S., & Stewart, W. J. (2005). Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 18(12), 1440–1463. doi:10.1016/j.echo.2005.10.005.
12. Gaggin, H. K., Truong, Q. A., Rehman, S. U., Mohammed, A. A., Bhardwaj, A., Parks, K. A., Sullivan, D. A., Chen-Tournoux, A., Moore, S. A., Richards, A. M., Troughton, R. W., Lainchbury, J. G., Weiner, R. B., Baggish, A. L., Semigran, M. J., & Januzzi, J. L., Jr. (2013). Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congestive Heart Failure, 19(3), 135–142. doi:10.1111/chf.12016.
13. Motiwala, S. R., Szymonifka, J., Belcher, A., Weiner, R. B., Baggish, A. L., Sluss, P., Gaggin, H. K., Bhardwaj, A., & Januzzi, J. L. (2013). Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. European Journal of Heart Failure, 15(10), 1157–1163. doi:10.1093/eurjhf/hft075.
14. Miller, W. L., Hartman, K. A., Burritt, M. F., Grill, D. E., & Jaffe, A. S. (2009). Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. Journal of the American College of Cardiology, 54(18), 1715–1721. doi:10.1016/j.jacc.2009.07.025.